A retrospective, observational multicenter study of CAZ-AVI therapy for infections caused by KPC-producing K. pneumoniae (KPC-Kp) strains
Latest Information Update: 26 Feb 2021
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Klebsiella infections; Respiratory tract infections; Urinary tract infections
- Focus Adverse reactions
- 26 Feb 2021 New trial record
- 22 Feb 2021 Results published in the Clinical Infectious Diseases